In the present study, we employed a well established JB6 mouse epithelial cell model to define the molecular mechanism of efficacy of a naturally occurring flavonoid silibinin against ultraviolet B (UVB)-induced skin tumorigenesis. UVB exposure of cells caused a moderate phosphorylation of ERK1/2 and Akt and a stronger phosphorylation of p53 at Ser 15 , which was enhanced markedly by silibinin pretreatment. Kinase activity of ERK1/2 for Elk-1 and Akt for glycogen synthase kinase-3†was also potently enhanced by silibinin pretreatment. Furthermore, silibinin increased the UVBinduced level of cleaved caspase 3 as well as apoptotic cells. Based on these observations, next we investigated the role of upstream kinases, ATM/ATR and DNA-PK, which act as sensors for UVB-induced DNA damage and transduce signals leading to DNA repair or apoptosis. Whereas UVB strongly activated ATM as observed by Ser 1981 phosphorylation, it was not affected by silibinin pretreatment. However, pretreatment of cells with the DNA-protein kinase (PK) inhibitor LY294002 strongly reversed silibinin-enhanced Akt-Ser 473 and p53-Ser 15 as well as ERK1/2 phosphorylation together with a dose-dependent decrease in cleaved caspase 3 and apoptosis (p < 0.05). In addition, silibinin pretreatment strongly enhanced H2A.X-Ser 139 phosphorylation and DNA-PKassociated kinase activity as well as the physical interaction of p53 with DNA-PK; pretreatment of cells with LY294002 but not caffeine abolished the silibinin-caused increase in both DNA-PK activation and p53-Ser 15 phosphorylations. Together, these findings suggest that silibinin preferentially activates the DNA-PK-p53 pathway for apoptosis in response to UVB-induced DNA damage, and that this could be a predominant mechanism of silibinin efficacy against UVB-induced skin cancer.
Ultraviolet B (UVB)1 radiation plays a major role in the development of non-melanoma skin cancer, which is the most common human malignancy in the United States (1). In recent years, chemoprevention is considered to be a promising strategy for the control of this malignancy, where several studies have shown that various phytochemicals from both nutritive and non-nutritive sources protect against UVB-induced skin cancer (2-6). In this regard, silymarin (a polyphenolic flavonoid antioxidant from milk thistle) and silibinin (the bioactive component in silymarin) have also shown strong potential in preventing UV-induced skin damages and photocarcinogenesis (2, 5-7). We have demonstrated the chemopreventive efficacy of silymarin/silibinin in the SKH-1 mouse skin model, where these agents showed strong protection against UVBinduced tumor initiation, tumor promotion, and complete carcinogenesis (2). We also found that silymarin protects against chemical carcinogenesis in SENCAR mouse skin by modulating mitogen-activated protein kinases (MAPKs) and inducing apoptosis (3). In a more recent study, we observed a strong protective effect of silibinin against UVB-induced skin carcinogenesis in SKH-1 mice where topical applications before o...